Using Practice Facilitators to Support Physicians for COVID-19 Vaccination

N/A

Waitlist Available

Led By Noah Ivers, MD

Research Sponsored by Women's College Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

6,690 family physicians across Ontario who have active (up-to-date passwords) ONE ID accounts

Timeline

Screening 3 weeks

Treatment Varies

Follow Up approximately 4 months (from time of randomization until follow-up completed end of fiscal year, march 31, 2022)

Awards & highlights

Study Summary

This trial is testing a practice facilitation intervention to help family physicians in Ontario access their patients' COVID-19 vaccination reports and communicate with unvaccinated patients. The facilitator will help develop action plans and offer a range of options, including co-hosted online town-halls, support for medical office assistants to coordinate patient outreach, and/or connection to trained, volunteer medical students that can help with patient outreach.

Eligible Conditions

Vaccine Uptake
COVID-19 Vaccination

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ approximately 4 months (from time of randomization until follow-up completed end of fiscal year, march 31, 2022)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~approximately 4 months (from time of randomization until follow-up completed end of fiscal year, march 31, 2022)

This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 4 months (from time of randomization until follow-up completed end of fiscal year, march 31, 2022) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Any vaccine dose during follow-up interval

Secondary outcome measures

1st vaccine dose during follow-up interval

2nd vaccine dose during follow-up interval

3rd vaccine dose during follow-up interval

+1 more

Other outcome measures

Any engagement

Calls by volunteers

Medical office assistant engagement

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention group: Practice facilitation and additional supportExperimental Treatment1 Intervention

Ontario Health will send out letters to physicians in the intervention group that will explain to them that they have a large group of eligible and unvaccinated patients and that an initiative is planned to support them in reaching out to those patients, with an embedded evaluation. It will ask them to reach out to the research team to plan a time to access the supports to gather more information, or to opt-out from the evaluation. Specifically, physicians will receive invitations to receive practice facilitation via mail letter and fax, followed by up to five weekly phone calls from a team member at Ontario Health.

Group II: Control group- No interventionActive Control1 Intervention

We choose to include a control group as we do not have the resources to deliver the intervention to the entire physician group. Cluster randomization by primary practice address will limit contamination.

0 / 1Eligibility criteria met